NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioLight Life Sciences Ltd (TA: BOLT)

 
BOLT Technical Analysis
5
As on 31st Mar 2026 BOLT SHARE Price closed @ 217.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 542.87 & Strong Sell for SHORT-TERM with Stoploss of 575.57 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BOLTSHARE Price

Open 238.60 Change Price %
High 238.60 1 Day -32.50 -12.98
Low 214.80 1 Week -112.10 -33.97
Close 217.90 1 Month -132.10 -37.74
Volume 29972 1 Year -312.10 -58.89
52 Week High 699.40 | 52 Week Low 217.90
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
ORL 135.50 -0.95%
APLY 259.40 1.57%
ARDM 259.40 1.57%
MGDL 1650.00 0.36%
LUMI 6979.00 3.10%
GNRS 244.80 0.82%
BEZQ 749.00 0.79%
DSCT 3148.00 2.94%
RATI-L 435.00 2.09%
 
TA Israel Top Gainers Stocks
MDIN-L 121.00 18.74%
TDGN-L 171.50 17.55%
MCRNT 372.50 16.84%
SAE 4593.00 14.82%
SAE 4593.00 14.82%
SAE 4593.00 14.82%
SAE 4593.00 14.82%
SAE 4593.00 14.82%
GAMT 1503.00 13.86%
HROD 5200.00 13.04%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
INTL 77.10 -18.50%
INTL 77.10 -18.50%
TEFN 77.10 -18.50%
TEFN 77.10 -18.50%
ULTR 74.10 -16.74%
RSEL 1546.00 -13.10%
BOLT 217.90 -12.98%
BOLT 217.90 -12.98%
BOLT 217.90 -12.98%
 
 
BOLT
Daily Charts
BOLT
Intraday Charts
Whats New @
Bazaartrend
BOLT
Free Analysis
 
BOLT Important Levels Intraday
RESISTANCE263.76
RESISTANCE249.05
RESISTANCE239.96
RESISTANCE230.87
SUPPORT204.93
SUPPORT195.84
SUPPORT186.75
SUPPORT172.04
 
BOLT Forecast April 2026
4th UP Forecast593.67
3rd UP Forecast473.16
2nd UP Forecast398.67
1st UP Forecast324.18
1st DOWN Forecast111.63
2nd DOWN Forecast37.14
3rd DOWN Forecast-37.36
4th DOWN Forecast-157.87
 
BOLT Weekly Forecast
4th UP Forecast363.00
3rd UP Forecast316.47
2nd UP Forecast287.70
1st UP Forecast258.94
1st DOWN Forecast176.86
2nd DOWN Forecast148.10
3rd DOWN Forecast119.33
4th DOWN Forecast72.80
 
BOLT Forecast2026
4th UP Forecast1156.73
3rd UP Forecast855.64
2nd UP Forecast669.53
1st UP Forecast483.42
1st DOWN Forecast-47.62
2nd DOWN Forecast-233.73
3rd DOWN Forecast-419.84
4th DOWN Forecast-720.93
 
 
BOLT Other Details
Segment EQ
Market Capital 5583224320.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BOLT Address
BOLT
 
BOLT Latest News
 
Your Comments and Response on BioLight Life Sciences Ltd
 
BOLT Business Profile
BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. The company's ophthalmic product offering and pipeline of product candidates include IOPtiMate, a laser-based surgical treatment for glaucoma; TeaRx, a point-of-care multi-parameter diagnostic test for dry eye syndrome; Eye-D, a controlled release drug-delivery insert platform; OphRx, a non-invasive topical drug delivery technology; and LipiTear, a micro-emulsion technology for the dry eye treatment, as well as for the treatment of other ocular diseases. It also invests in cancer diagnostics technologies, including proprietary tests that are designated for bladder, cervical, multiple myeloma, and other cancers. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. Address: Atidim Park Tel Aviv, Tel Aviv, Israel, 6158101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service